Advertisement
Advertisement

IART

IART logo

Integra LifeSciences Holdings

14.38
USD
Sponsored
+0.27
+1.91%
May 19, 15:59 UTC -4
Closed
exchange

After-Market

14.37

-0.01
-0.07%

IART Earnings Reports

Positive Surprise Ratio

IART beat 25 of 42 last estimates.

60%

Next Report

Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$427.14M
/
$0.49
Implied change from Q1 26 (Revenue/ EPS)
+8.99%
/
-9.26%
Implied change from Q2 25 (Revenue/ EPS)
+2.78%
/
+8.89%

Integra LifeSciences Holdings earnings per share and revenue

On May 05, 2026, IART reported earnings of 0.54 USD per share (EPS) for Q1 26, beating the estimate of 0.41 USD, resulting in a 30.88% surprise. Revenue reached 391.92 million, compared to an expected 391.04 million, with a 0.23% difference. The market reacted with a +24.13% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 10 analysts forecast an EPS of 0.49 USD, with revenue projected to reach 427.14 million USD, implying an decrease of -9.26% EPS, and increase of 8.99% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ClearPoint Neuro, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.32
Surprise
-14.78%
logo
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.31
Surprise
-23.21%
logo
QT Imaging Holdings, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.25
Surprise
-81.29%
logo
Solana Company Class A Common Stock (DE)
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.48
Actual
-$1.03
Surprise
-110.38%
logo
DarioHealth Corp. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.50
Actual
-$1.25
Surprise
+17.20%
logo
SiNtx Technologies, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.67
Actual
-$0.70
Surprise
-3.98%
logo
PAVmed Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.71
Actual
-$4.42
Surprise
-519.05%
logo
Tenon Medical, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+6.78%
logo
NexGel, Inc Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.11
Surprise
-54.06%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$1.25
Actual
-$1.80
Surprise
-43.47%
FAQ
For Q1 2026, Integra LifeSciences Holdings reported EPS of $0.54, beating estimates by 30.88%, and revenue of $391.92M, 0.23% above expectations.
The stock price moved up 24.13%, changed from $10.65 before the earnings release to $13.22 the day after.
The next earning report is scheduled for Jul 29, 2026.
Based on 10 analysts, Integra LifeSciences Holdings is expected to report EPS of $0.49 and revenue of $427.14M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement